Vanda Pharmaceuticals Inc. today announced that it will participate at the following upcoming investor conferences in November 2018
WASHINGTON, Nov. 8, 2018 /PRNewswire/ -- Vanda Pharmaceuticals, Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at the following upcoming investor conferences in November 2018:
The Stifel 2018 Healthcare Conference in New York City on Tuesday, November 13, 2018. A corporate presentation is scheduled for 2:00 p.m. Eastern Time.
The Jefferies 2018 London Healthcare Conference in London, England on Thursday, November 15, 2018. A corporate presentation is scheduled for 4:40 p.m. Greenwich Mean Time (11:40 a.m. Eastern Time).
The corporate presentations given at the Stifel and Jefferies conferences will be available live on Vanda’s corporate website, where they also will be archived for 30 days. To access the presentations, go to Vanda’s website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentations.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.
Company Contact:
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-november-2018-investor-conferences-300747185.html
SOURCE Vanda Pharmaceuticals Inc.
Company Codes: NASDAQ-NMS:VNDA
